| Record Information |
| Version |
3.5 |
| Creation Date |
2005-11-16 08:48:42 -0700 |
| Update Date |
2013-02-08 17:09:37 -0700 |
| HMDB ID |
HMDB00939 |
| Secondary Accession Numbers |
None |
| Metabolite Identification |
| Common Name |
S-Adenosylhomocysteine |
| Description |
S-Adenosylhomocysteine (AdoHcy) is the immediate precursor of all of the homocysteine produced in the body. The reaction is catalyzed by S-adenosylhomocysteine hydrolase and is reversible with the equilibrium favoring formation of AdoHcy. In vivo, the reaction is driven in the direction of homocysteine formation by the action of the enzyme adenosine deaminase, which converts the second product of the S-adenosylhomocysteine hydrolase reaction, adenosine, to inosine. Except for methyl transfer from betaine and from methylcobalamin in the methionine synthase reaction, AdoHcy is the product of all methylation reactions that involve S-adenosylmethionine (AdoMet) as the methyl donor. Methylation is significant in epigenetic regulation of protein expression via DNA and histone methylation. The inhibition of these AdoMet-mediated processes by AdoHcy is a proven mechanism for metabolic alteration. Because the conversion of AdoHcy to homocysteine is reversible, with the equilibrium favoring the formation of AdoHcy, increases in plasma homocysteine are accompanied by an elevation of AdoHcy in most cases. Disturbances in the transmethylation pathway indicated by abnormal S-adenosylmethionine, S-adenosylhomocysteine or their ratio have been reported in many neurodegenerative diseases, such as dementia, depression or Parkinson's disease. (PMID: 18065573 , 17892439 ). |
| Structure |
Download:
MOL |
SDF |
SMILES |
InChI
Display:
2D Structure |
3D Structure
|
| Synonyms |
- (S)-5'-(S)-(3-Amino-3-carboxypropyl)-5'-thioadenosine
- 2-S-Adenosyl-L-homocysteine
- 5'-Deoxy-S-adenosyl-L-homocysteine
- 5'-S-(3-Amino-3-carboxypropyl)-5'-thio-L-Adenosine
- Adenosyl-homo-CYS
- Adenosyl-L-homocysteine
- Adenosylhomo-CYS
- Adenosylhomocysteine
- Adohcy
- Formycinylhomocysteine
- L-5'-S-(3-Amino-3-carboxypropyl)-5'-thior-Adenosine
- L-S-Adenosyl-Homocysteine
- L-S-Adenosylhomocysteine
- S-(5'-Adenosyl)-L-homocysteine
- S-(5'-Deoxyadenosin-5'-yl)-L-homocysteine
- S-(5'-Deoxyadenosine-5')-L-homocysteine
- S-Adenosyl-homocysteine
- S-Adenosyl-L-homocysteine
- SAH
|
| Chemical Formula |
C14H20N6O5S |
| Average Molecular Weight |
384.411 |
| Monoisotopic Molecular Weight |
384.12158847 |
| IUPAC Name |
(2S)-2-amino-4-({[(2S,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl}sulfanyl)butanoic acid |
| Traditional IUPAC Name |
S-adenosyl-L-homocysteine |
| CAS Registry Number |
979-92-0 |
| SMILES |
N[C@@H](CCSC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C(N)N=CN=C12)C(O)=O |
| InChI Identifier |
InChI=1S/C14H20N6O5S/c15-6(14(23)24)1-2-26-3-7-9(21)10(22)13(25-7)20-5-19-8-11(16)17-4-18-12(8)20/h4-7,9-10,13,21-22H,1-3,15H2,(H,23,24)(H2,16,17,18)/t6-,7+,9+,10+,13+/m0/s1 |
| InChI Key |
ZJUKTBDSGOFHSH-WFMPWKQPSA-N |
| Chemical Taxonomy |
| Kingdom |
Organic Compounds |
| Super Class |
Amino Acids, Peptides, and Analogues |
| Class |
Amino Acids and Derivatives |
| Sub Class |
Glycoamino Acids and Derivatives |
| Other Descriptors |
- Aromatic Heteropolycyclic Compounds
- Purine Nucleosides and Analogues
- amino acid zwitterion(ChEBI)
|
| Substituents |
- 1,2 Diol
- Alpha Amino Acid Or Derivative
- Aminopyrimidine
- Carboxylic Acid
- Glycosyl Compound
- Imidazole
- Imidazopyrimidine
- N Glycosyl Compound
- Oxolane
- Pentose Monosaccharide
- Polyamine
- Primary Aliphatic Amine (Alkylamine)
- Purine
- Pyrimidine
- Saccharide
- Secondary Alcohol
- Thioether
|
| Direct Parent |
Glycoamino Acids and Derivatives |
| Ontology |
| Status |
Detected and Quantified |
| Origin |
|
| Biofunction |
- Component of Arginine and proline metabolism
- Component of Glycerophospholipid metabolism
- Component of Glycine, serine and threonine metabolism
- Component of Histidine metabolism
- Component of Methionine metabolism
- Component of Nicotinate and nicotinamide metabolism
- Component of Selenoamino acid metabolism
- Component of Tryptophan metabolism
- Component of Tyrosine metabolism
- Component of Ubiquinone biosynthesis
|
| Application |
Not Available |
| Cellular locations |
- Mitochondria
- Nucleus
- Endoplasmic reticulum
|
| Physical Properties |
| State |
Solid |
| Experimental Properties |
| Property |
Value |
Reference |
| Melting Point |
209 - 211 °C |
Not Available |
| Boiling Point |
Not Available |
Not Available |
| Water Solubility |
Not Available |
Not Available |
| LogP |
Not Available |
Not Available |
|
| Predicted Properties |
|
| Spectra |
|
| 1H NMR Spectrum |
| MS/MS Spectrum LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) |
| MS/MS Spectrum LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) |
| MS/MS Spectrum LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) |
| MS/MS Spectrum LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) |
| MS/MS Spectrum LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) |
| MS/MS Spectrum LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) |
| MS/MS Spectrum LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) |
| MS/MS Spectrum LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) |
| MS/MS Spectrum LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) |
| MS/MS Spectrum LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) |
| MS/MS Spectrum LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) |
| MS/MS Spectrum LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) |
| MS/MS Spectrum LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) |
| MS/MS Spectrum LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) |
| MS/MS Spectrum LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) |
| [1H,1H] 2D NMR Spectrum |
| [1H,13C] 2D NMR Spectrum |
|
| Biological Properties |
| Cellular Locations |
- Mitochondria
- Nucleus
- Endoplasmic reticulum
|
| Biofluid Locations |
- Blood
- Cerebrospinal Fluid (CSF)
|
| Tissue Location |
- Neuron
- Placenta
- Myelin
- Prostate
- Lymphoblast
|
| Pathways |
|
| Normal Concentrations |
|
| Blood |
Detected and Quantified |
|
0.46 +/- 0.02 uM |
Elderly (>65 years old) |
Both |
Normal |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
0.01 (0.009-0.014) uM |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
0.0243 +/- 0.0068 uM |
Not Specified |
Not Specified |
Normal |
Not Available |
|
| Abnormal Concentrations |
|
| Blood |
Detected and Quantified |
|
0.016 (0.009-0.025) uM |
Adult (>18 years old) |
Both |
Neurodegenerative diseases |
Not Available |
| Blood |
Detected and Quantified |
|
0.49 +/- 0.05 uM |
Elderly (>65 years old) |
Both |
Parkinson's Disease |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
0.0269 +/- 0.0062 uM |
Adult (>18 years old) |
Not Specified |
Alzheimer's disease |
Not Available |
|
| Associated Disorders and Diseases |
| Disease References |
| Parkinson's disease |
- Cheng H, Gomes-Trolin C, Aquilonius SM, Steinberg A, Lofberg C, Ekblom J, Oreland L: Levels of L-methionine S-adenosyltransferase activity in erythrocytes and concentrations of S-adenosylmethionine and S-adenosylhomocysteine in whole blood of patients with Parkinson's disease. Exp Neurol. 1997 Jun;145(2 Pt 1):580-5.
Pubmed: 9217094
|
| Neurodegenerative disease |
- Obeid R, Kostopoulos P, Knapp JP, Kasoha M, Becker G, Fassbender K, Herrmann W: Biomarkers of folate and vitamin B12 are related in blood and cerebrospinal fluid. Clin Chem. 2007 Feb;53(2):326-33. Epub 2007 Jan 2.
Pubmed: 17200133
|
|
| Associated OMIM IDs |
|
| External Links |
| DrugBank ID |
Not Available |
| Phenol Explorer Compound ID |
Not Available |
| Phenol Explorer Metabolite ID |
Not Available |
| FoodDB ID |
FDB022327 |
| KNApSAcK ID |
Not Available |
| Chemspider ID |
388301  |
| KEGG Compound ID |
C00021  |
| BioCyc ID |
ADENOSYL-HOMO-CYS  |
| BiGG ID |
33543  |
| Wikipedia Link |
SAH  |
| NuGOwiki Link |
HMDB00939  |
| Metagene Link |
HMDB00939  |
| METLIN ID |
296  |
| PubChem Compound |
439155  |
| PDB ID |
SAH  |
| ChEBI ID |
16680  |
| References |
| Synthesis Reference |
Holy, Antonin; Rosenberg, Ivan. Studies on S-adenosyl-L-homocysteine hydrolase. Part XV. An improved synthesis of S-adenosyl-L-homocysteine and related compounds. Collection of Czechoslovak Chemical Communications (1985), 50(7), 1514-18. |
| Material Safety Data Sheet (MSDS) |
Download (PDF)
|
| General References |
- Miller AL: The methionine-homocysteine cycle and its effects on cognitive diseases. Altern Med Rev. 2003 Feb;8(1):7-19.
Pubmed: 12611557
- Hershfield MS, Kredich NM, Koller CA, Mitchell BS, Kurtzberg J, Kinney TR, Falletta JM: S-adenosylhomocysteine catabolism and basis for acquired resistance during treatment of T-cell acute lymphoblastic leukemia with 2'-deoxycoformycin alone and in combination with 9-beta-D-arabinofuranosyladenine. Cancer Res. 1983 Jul;43(7):3451-8.
Pubmed: 6601986
- Struys EA, Jansen EE, de Meer K, Jakobs C: Determination of S-adenosylmethionine and S-adenosylhomocysteine in plasma and cerebrospinal fluid by stable-isotope dilution tandem mass spectrometry. Clin Chem. 2000 Oct;46(10):1650-6.
Pubmed: 11017945
- Wang J, Dudman NP, Wilcken DE: Effects of homocysteine and related compounds on prostacyclin production by cultured human vascular endothelial cells. Thromb Haemost. 1993 Dec 20;70(6):1047-52.
Pubmed: 8165599
- Palella TD, Schatz RA, Wilens TE, Fox IH: S-Adenosylhomocysteine accumulation and selective cytotoxicity in cultured J Lab Clin Med. 1982 Aug;100(2):269-78.
Pubmed: 6980250
- van Guldener C, Stehouwer CD: Homocysteine and methionine metabolism in renal failure. Semin Vasc Med. 2005 May;5(2):201-8.
Pubmed: 16047272
- Muskiet FA: The importance of (early) folate status to primary and secondary coronary artery disease prevention. Reprod Toxicol. 2005 Sep-Oct;20(3):403-10.
Pubmed: 15964170
- Augoustides-Savvopoulou P, Luka Z, Karyda S, Stabler SP, Allen RH, Patsiaoura K, Wagner C, Mudd SH: Glycine N -methyltransferase deficiency: a new patient with a novel mutation. J Inherit Metab Dis. 2003;26(8):745-59.
Pubmed: 14739680
- Fowler B: Homocysteine: overview of biochemistry, molecular biology, and role in disease processes. Semin Vasc Med. 2005 May;5(2):77-86.
Pubmed: 16047261
- Gordon RK, Ginalski K, Rudnicki WR, Rychlewski L, Pankaskie MC, Bujnicki JM, Chiang PK: Anti-HIV-1 activity of 3-deaza-adenosine analogs. Inhibition of S-adenosylhomocysteine hydrolase and nucleotide congeners. Eur J Biochem. 2003 Sep;270(17):3507-17.
Pubmed: 12919315
- Metz J: Cobalamin deficiency and the pathogenesis of nervous system disease. Annu Rev Nutr. 1992;12:59-79.
Pubmed: 1354465
- Mulder C, Schoonenboom NS, Jansen EE, Verhoeven NM, van Kamp GJ, Jakobs C, Scheltens P: The transmethylation cycle in the brain of Alzheimer patients. Neurosci Lett. 2005 Sep 30;386(2):69-71.
Pubmed: 16040194
- Delabar U, Kloor D, Luippold G, Muhlbauer B: Simultaneous determination of adenosine, S-adenosylhomocysteine and S-adenosylmethionine in biological samples using solid-phase extraction and high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl. 1999 Mar 19;724(2):231-8.
Pubmed: 10219663
- Hermes M, von Hippel S, Osswald H, Kloor D: S-adenosylhomocysteine metabolism in different cell lines: effect of hypoxia and cell density. Cell Physiol Biochem. 2005;15(5):233-44.
Pubmed: 15956786
- Weir DG, Molloy AM, Keating JN, Young PB, Kennedy S, Kennedy DG, Scott JM: Correlation of the ratio of S-adenosyl-L-methionine to S-adenosyl-L-homocysteine in the brain and cerebrospinal fluid of the pig: implications for the determination of this methylation ratio in human brain. Clin Sci (Lond). 1992 Jan;82(1):93-7.
Pubmed: 1310924
- Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, Yu J, Laxman B, Mehra R, Lonigro RJ, Li Y, Nyati MK, Ahsan A, Kalyana-Sundaram S, Han B, Cao X, Byun J, Omenn GS, Ghosh D, Pennathur S, Alexander DC, Berger A, Shuster JR, Wei JT, Varambally S, Beecher C, Chinnaiyan AM: Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature. 2009 Feb 12;457(7231):910-4.
Pubmed: 19212411
|
| Enzymes |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Name: |
Arsenite methyltransferase
|
| Reactions: |
- (1) S-adenosyl-L-methionine + arsenite = S-adenosyl-L-homocysteine + methylarsonate [RN:R05755]
- (2) S-adenosyl-L-methionine + methylarsonite = S-adenosyl-L-homocysteine + dimethylarsinate [RN:R05756]
|
| Gene Name: |
AS3MT |
| Uniprot ID: |
Q9HBK9  |
| Protein Sequence: |
FASTA |
| Gene Sequence: |
FASTA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Name: |
Methionine synthase reductase
|
| Reactions: |
- 2 [methionine synthase]-methylcob(I)alamin + 2 S-adenosylhomocysteine + NADP+ = 2 [methionine synthase]-cob(II)alamin + NADPH + H+ + 2 S-adenosyl-L-methionine [RN:R05182]
|
| Gene Name: |
MTRR |
| Uniprot ID: |
Q9UBK8  |
| Protein Sequence: |
FASTA |
| Gene Sequence: |
FASTA |
|
|
|
|
|
|
|
|
|
|
|
| Name: |
Histamine N-methyltransferase
|
| Reactions: |
- S-adenosyl-L-methionine + histamine = S-adenosyl-L-homocysteine + Ntau-methylhistamine [RN:R02155]
|
| Gene Name: |
HNMT |
| Uniprot ID: |
P50135  |
| Protein Sequence: |
FASTA |
| Gene Sequence: |
FASTA |
|
| Name: |
Thiopurine S-methyltransferase
|
| Reactions: |
- S-adenosyl-L-methionine + a thiopurine = S-adenosyl-L-homocysteine + a thiopurine S-methylether [RN:R03701]
|
| Gene Name: |
TPMT |
| Uniprot ID: |
P51580  |
| Protein Sequence: |
FASTA |
| Gene Sequence: |
FASTA |
|
|
|
|
|
| Name: |
Adenosylhomocysteinase
|
| Reactions: |
- S-adenosyl-L-homocysteine + H2O = L-homocysteine + adenosine [RN:R00192]
|
| Gene Name: |
AHCY |
| Uniprot ID: |
P23526  |
| Protein Sequence: |
FASTA |
| Gene Sequence: |
FASTA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Name: |
mRNA cap guanine-N7 methyltransferase
|
| Reactions: |
- S-adenosyl-L-methionine + G(5')pppR-RNA = S-adenosyl-L-homocysteine + m7G(5')pppR-RNA (mRNA containing an N7-methylguanine cap) [RN:R03805]
|
| Gene Name: |
RNMT |
| Uniprot ID: |
O43148  |
| Protein Sequence: |
FASTA |
| Gene Sequence: |
FASTA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|